Buy Austedo 6mg-USA Deutetrabenazine

Austedo 6mg tablets contain deutetrabenazine, a vesicular monoamine transporter 2 inhibitor used for movement disorder management. This prescription medication helps regulate neurotransmitter release in the brain. Austedo is indicated for chorea associated with Huntington's disease and tardive dyskinesia. Austedo 6mg provides targeted symptom control.

Strength

6mg

Manufacturer / TM Owner

Teva Pharmaceuticals USA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Deutetrabenazine is prescribed to reduce involuntary movements caused by chorea in Huntington’s disease and symptoms of tardive dyskinesia. It works by modulating dopamine release in the brain, helping stabilize motor control. Austedo 6mg is used when symptoms interfere with daily function. This medication is not a cure but may improve quality of life.

Side Effects

Austedo 6mg may help reduce jerky, uncontrollable movements over time with consistent use. Some users report improved coordination and reduced muscle spasms. Effects vary by individual and may take several weeks to become noticeable. Regular monitoring by a healthcare provider is recommended to assess response.

Precautions & Warnings

Store Austedo 6mg tablets at room temperature away from moisture and heat. Keep out of reach of children and pets. Do not use if the seal is broken or the medication shows discoloration. Inform your doctor of all current medications and medical conditions before starting treatment.

Avoid Interactions

Austedo may interact with medications that affect liver enzymes, such as strong CYP2D6 inhibitors or inducers. Combining with alcohol or sedatives could increase drowsiness. Always consult a healthcare provider before combining with other central nervous system depressants. Grapefruit products may also affect how Austedo works.

References

Frequently Asked Questions

Austedo 6mg is used to treat chorea associated with Huntington’s disease and symptoms of tardive dyskinesia.

Effects may take several weeks to become noticeable as the medication builds up in the body.

Alcohol may increase drowsiness; consult your doctor before consuming alcohol with this medication.

Yes, Austedo is classified as a Schedule IV controlled substance due to its potential for abuse.

Take the missed dose as soon as you remember unless it’s close to the next scheduled dose; skip it if so.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.